Publicaciones (103) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. Mitochondrial CB 1 receptors regulate neuronal energy metabolism

    Nature Neuroscience, Vol. 15, Núm. 4, pp. 558-564

  2. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis

    Journal of Neuroimmune Pharmacology, Vol. 7, Núm. 4, pp. 1002-1016

  3. A pathogenic mechanism in huntington's disease involves small CAG-repeated RNAs with neurotoxic activity

    PLoS Genetics, Vol. 8, Núm. 2

  4. Acondroplasia: una enfermedada olvidada

    Lychnos, Núm. 10, pp. 74

  5. Activation of the cholinergic anti-inflammatory system in peripheral blood mononuclear cells from patients with Borderline Personality Disorder

    Journal of Psychiatric Research, Vol. 46, Núm. 12, pp. 1610-1617

  6. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation

    Journal of Cell Science, Vol. 125, Núm. 1, pp. 176-188

  7. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  8. Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication

    Stroke, Vol. 43, Núm. 6, pp. 1647-1653

  9. Are adults diagnosed with diabetes achieving the American Diabetes Association clinical practice recommendations?

    Puerto Rico Health Sciences Journal, Vol. 31, Núm. 1, pp. 18-23

  10. Autophagy and misfolded proteins in neurodegeneration

    Experimental Neurology, Vol. 238, Núm. 1, pp. 22-28

  11. Bim Inhibits Autophagy by Recruiting Beclin 1 to Microtubules

    Molecular Cell, Vol. 47, Núm. 3, pp. 359-370

  12. CB 2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling

    Journal of Biological Chemistry, Vol. 287, Núm. 2, pp. 1198-1209

  13. Ca2+-activated nucleotidase 1, a novel target gene for the transcriptional repressor DREAM (Downstream Regulatory Element Antagonist Modulator), is involved in protein folding and degradation

    Journal of Biological Chemistry, Vol. 287, Núm. 22, pp. 18478-18491

  14. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function

    Neuropharmacology, Vol. 63, Núm. 5, pp. 776-783

  15. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection

    Stroke, Vol. 43, Núm. 1, pp. 211-219

  16. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

    Neuropharmacology, Vol. 62, Núm. 7, pp. 2299-2308

  17. Cannabinoids: A new hope for breast cancer therapy?

    Cancer Treatment Reviews, Vol. 38, Núm. 7, pp. 911-918

  18. Cannabinoids: Novel medicines for the treatment of Huntington's disease

    Recent Patents on CNS Drug Discovery, Vol. 7, Núm. 1, pp. 41-48

  19. Changes in Diadenosine Polyphosphates during Alignment-Fit and Orthokeratology Rigid Gas Permeable Lens Wear

    Investigative Ophthalmology and Visual Science, Vol. 53, Núm. 8, pp. 4426-4432

  20. Changes in the serotonergic system and in brain-derived neurotrophic factor distribution in the main olfactory bulb of pcd mice before and after mitral cell loss

    Neuroscience, Vol. 201, pp. 20-33